| 名稱 | AI-Edigene® FGFR2(E17)- BICC1(E3) Translocati |
| 型號 | CBP20188D |
| 報價 | ![]() |
| 特點 | AI-Edigene® FGFR2(E17)- BICC1(E3) Translocation |
產(chǎn)品搜索
相關(guān)文章
- Cell Rep:發(fā)現(xiàn)治療乳腺癌轉(zhuǎn)移的重要新靶標(biāo)!
- 認(rèn)識下北京細(xì)胞庫的質(zhì)量管理要求
- 剖析正常細(xì)胞是如何成長為腫瘤細(xì)胞的
- 心衰治療靶點:BNP/NPR1
- 【連載-企業(yè)參考品】胃癌的診斷參考品的選擇
- 【新品發(fā)布】血液系統(tǒng)惡性腫瘤標(biāo)準(zhǔn)品-27基因-38位點
- 假病毒標(biāo)準(zhǔn)品
- 國內(nèi)研究者Cell Research:韓春雨NgAgo有效
- 百時美免疫組合治療非小細(xì)胞肺癌展現(xiàn)驚人療效
- CCR8 | 潛在重磅腫瘤免疫治療靶點
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > Translocation > CBP20188DAI-Edigene® FGFR2(E17)- BICC1(E3) Translocati
- 詳細(xì)內(nèi)容
CBP20188D | |
| Format | DNA |
| Description | FGFR2, fibroblast growth factor receptor 2, is a receptor tyrosine kinase activated upon binding of the FGF ligand, which activates RAS-MAPK and PI3K-AKT pathways. Altered function of FGFR2 through activating mutations, fusions, and amplification increases cell proliferation and tumorigenesis and is observed in prostate, breast, lung, uterine, and ovarian cancers, while FGFR2 amplification and overexpression is commonly observed in gastric cancer. |
| Technical Data | |
| Left Gene | FGFR2 |
| Left Breakpoint | chr10:1232****1:- (hg19) |
| Right Gene | BICC1 |
| Right Breakpoint | chr10:60****4:+ (hg19) |
| %AF | N/A |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">





